Streetbeat News

Products Services

AZN

Astrazeneca has released data from four pivotal Phase III trials at ESMO, highlighting the effectiveness of its cancer treatments. The data includes results for TROPION-Lung01 and TROPION-Breast01, FLAURA2, DUO-E, and MATTERHORN Phase III trials, showcasing the potential of datopotamab deruxtecan, TAGRISSO, IMFINZI, and LYNPARZA in treating various types of cancers.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 11:02 am

ORGN

Origin Materials has announced the commencement of commercial-scale production at its Origin 1 plant. The plant will convert sustainable wood residues into intermediate chemicals, targeting a ~$1 trillion addressable market. The chemicals produced can be used in a variety of end-products, including bio-based apparel and textiles, green tires for the automotive industry, and bio-based and fully recyclable packaging.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 11:01 am

AAPL

GOOG

GOOGL

California has passed the Right to Repair Act, backed by Apple Inc. (NASDAQ:AAPL), which allows consumers to repair their devices at third-party shops. The law, which comes into effect from July 1, 2024, mandates manufacturers to make repair parts available for seven years for products costing over $100 and three years for those under $100. Companies failing to comply will face fines. The law is seen as a win for consumers and environmental sustainability. Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google has also responded to the movement by providing seven years of software updates for its Pixel 8 series.

Portfolio Pulse from Rounak Jain

October 11, 2023 | 10:44 am

IMUX

Immunic has presented data from its Phase 2 EMPhASIS trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at the 9th Joint ECTRIMS-ACTRIMS Meeting. The data shows improvement in Serum Neurofilament Light Chain (NfL) in both treatment arms of Vidofludimus Calcium over placebo. This is consistent with data from the separate Phase 2 CALLIPER trial of Vidofludimus Calcium in Progressive Multiple Sclerosis.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:36 am

GELYF

GELYY

China's Geely Holding Group has entered into a Master Collaboration Agreement with DRB-HICOM Berhad to develop Malaysia's Automotive Hi-Tech Valley. The project aims to emphasize the manufacturing of automobiles and the creation of high-tech components for new energy vehicles. DRB is the majority shareholder of Malaysian car maker Proton, in which Geely also has a 49.9% stake.

Portfolio Pulse from Shivani Kumaresan

October 11, 2023 | 10:32 am

STLA

Stellantis N.V. and Samsung SDI have announced Kokomo, Indiana as the site for a second battery manufacturing facility in the US as part of the StarPlus Energy joint venture. The new plant is expected to start production in 2027 with an annual capacity of 34 GWh. The joint venture will invest over $3.2 billion and create 1,400 new jobs. The total investment for both facilities will be over $6.3 billion, creating 2,800 total new jobs.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:05 am

BCDA

BioCardia, Inc. (NASDAQ:BCDA) has completed enrollment for its CardiAMP Heart Failure Trial and is initiating discussions with the FDA for a second pivotal study protocol. The aim of the second study is to gain FDA marketing approval.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:02 am

AMZN

BBY

WMT

Mozilla Firefox is set to introduce a built-in fake reviews detector for popular e-commerce websites such as Amazon.com Inc., Best Buy Co Inc., and Walmart Inc. The feature, enabled by an add-on called Fakespot, uses AI and machine learning to detect patterns and similarities between reviews to flag deceptive ones. The feature adjusts the rating based on its findings and labels sellers based on their reliability. Mozilla acquired Fakespot in May this year.

Portfolio Pulse from Rounak Jain

October 11, 2023 | 10:01 am

PEP

PepsiCo Inc.'s CEO, Ramon Laguarta, has stated that the rise in weight loss and diabetes medications has had a negligible effect on the company's business. Despite warnings about the potential impact of appetite-suppressing drugs on food consumption habits, Laguarta remains confident in PepsiCo's strategy of offering healthier options and smaller package sizes. The company has reported a nearly 7% rise in net sales to $23.45 billion and has adjusted its full-year forecast upwards for the third consecutive quarter.

Portfolio Pulse from Benzinga Neuro

October 11, 2023 | 9:36 am

DXC

DXC Technology has been awarded a contract by the Agency for the Technological Modernization of Galicia to transform its cloud platforms and solutions. DXC will manage and develop the organization’s cloud infrastructures across private, public and cloud environments. The agreement will benefit decision-making processes for the government agency, with DXC providing advice on methodologies, best practices, cost optimization, regulatory compliance, governance, and the implementation of new cloud services.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 9:09 am